Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population

Carcinogenesis

Volumn 30, Issue 10, 2009, Pages 1729-1734

  Imaizumi, Takeshi ^a,b   Higaki, Yasuki ^c   Hara, Megumi ^a   Sakamoto, Tatsuhiko ^d   Horita, Mikako ^a   Mizuta, Toshihiko ^b   Eguchi, Yuichiro ^b   Yasutake, Tsutomu ^b   Ozaki, Iwata ^b   Yamamoto, Kyosuke ^b   Onohara, Shingo ^e   Kawazoe, Seiji ^e   Shigematsu, Hirohisa ^e   Koizumi, Shunzo ^b   Kudo, Sho ^b   Tanaka, Keitaro ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d Asakura Health Welfare Environment Office   (Japan)

^e Saga Prefectural Hospital Koseikan   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1; GLYCINE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENINE; ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GUANINE; HUMANS; INCIDENCE; JAPAN; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 70349994806     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp191     Document Type: Article

References (40)

1. International Agency for Research on Cancer. (2004) Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum., 83, 1179-1187.
2. Tanaka,K. et al. (2006) Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Jpn. J. Clin. Oncol., 36, 445-456.
3. Ikai,I. et al. (2007) Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol. Res., 37, 676-691.
4. Hara,M. et al. (2008) Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci., 99, 93-97.
5. International Agency for Research on Cancer. (2004) Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum., 83, 59-94.
6. Smith,G. et al. (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surv., 25, 27-65.
7. Wu,X. et al. (2004) Genetic susceptibility to tobacco-related cancer. Oncogene, 23, 6500-6523.
8. Blum,H.E. (2001) Hepatocellular carcinoma: Susceptibility markers. IARC Sci. Publ., 154, 241-244.
9. Yu,M.W. et al. (1995) Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-1273.
10. Yu,M.W. et al. (1999) Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br. J. Cancer, 80, 598-603.
11. Yu,M.W. et al. (2000) Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk. Gut, 47, 703-709.
12. Munaka,M. et al. (2003) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol., 129, 355-360.
13. Gelatti,U. et al. (2005) N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: A case-control study. Int. J. Cancer, 115, 301-306.
14. Chen,X. et al. (2006) Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: A case-control study in a high-risk region of China. Pharmacogenet. Genomics, 16, 219-227.
15. Tanaka,K. et al. (1996) Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: Possible role of type 1b (II) infection. J. Natl Cancer Inst., 88, 742-746.
16. Cascorbi,I. et al. (1996) A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56, 4965-4969.
17. Chida,M. et al. (1999) Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn. J. Cancer Res., 90, 899-902.
18. Ariyoshi,N. et al. (2000) Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics, 10, 687-693.
19. Maezawa,Y. et al. (1994) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis. Am. J. Gastroenterol. 89, 561-565.
20. Bell,D.A. et al. (1993) Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
21. Abe,M. et al. (1993) An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction. Jpn. J. Hum. Genet., 38, 163-168.
22. Nakajima,M. et al. (1999) Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans. J. Biochem., 125, 803-808.
23. Mahavorasirikul,W. et al. (2009) CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking. Eur. J. Clin. Pharmacol., 65 377-384.
24. Gonzalez,F.J. et al. (1996) Constitutive expression of hepatic cytochrome P450 genes. FASEB J., 10, 1112-1117.
25. Koskela,S. et al. (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol., 57, 1407-1413.
26. Rowe,J.D. et al. (1997) Subunit diversity and tissue distribution of human glutathione S-transferases: Interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem. J., 325, (Pt 2), 481-486.
27. Windmill,K.F. et al. (2000) Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol. Sci., 54, 19-29.
28. Sakamoto,T. et al. (2006) Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population. Int. J. Cancer, 118, 1501-1507.
29. Vatsis,K.P. et al. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-17.
30. White,D.L. et al. (2008) Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: A HuGE systematic review and meta-analysis. Am. J. Epidemiol., 167, 377-389.
31. Silvestri,L. et al. (2003) CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Int. J. Cancer, 104, 310-317.
32. Mochizuki,J. et al. (2005) Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma. J. Gastroenterol. Hepatol., 20, 1191-1197.
33. Guengerich,F.P. et al. (1992) Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology. Environ. Health Perspect., 98, 75-80.
34. Baker,J.R. et al. (2001) Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples. Biochem. Pharmacol., 62, 713-721.
35. Koide,A. et al. (1999) Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver. Mutat. Res. 428, 165-176.
36. Manabe,S. et al. (1991) Detection of a carcinogen, 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis, 12, 1945-1947.
37. Wakabayashi,K. et al. (1993) Exposure to heterocyclic amines. Environ. Health Perspect., 99, 129-134.
38. Tsuda,H. et al. (2003) Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: Evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work. Toxicol. Pathol., 31, 80-86.
39. Ito,N. et al. (1991) Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses. Carcinogenesis, 12, 767-772.
40. Hasegawa,R. et al. (1994) Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses. Carcinogenesis, 15, 1037-1041.